Literature DB >> 14695762

Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand.

Liu-Qin Yang1, Dian-Chun Fang, Rong-Quan Wang, Shi-Ming Yang.   

Abstract

AIM: To study the effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on tumor necrosis factors related apoptosis inducing ligand (TRAIL) induced apoptosis of gastric cancer cells.
METHODS: Gastric cancer cells of SGC-7901, MKN28, MKN45 and AGS lines were cultured in PRMI-1640 medium and the apoptosis rates of the cells of 4 lines were observed after treatment of tumor necrosis factors related apoptosis inducing ligand (TRAIL) with a flow cytometer. The expression of NF-kappaB, survivin, Bcl-2 and Caspase3 in gastric cancer cells of 4 lines was analyzed with Western blot.
RESULTS: After the gastric cancer cells were exposed to TRAIL 300 ng/ml for 24 hours, the apoptosis rate was 36.05%, 20.27%, 16.50% and 11.80% in MKN28, MKN45, AGS and SGC-7901cells respectively. Western blot revealed that the expressions of NF-kappaB and survivin were lower in MKN28 cells than in MKN45, AGS and SGC-7901 cells. In contrast, the expression of Caspase3 was higher in MKN28 cells than in MKN45, AGS and SGC-7901 cells.
CONCLUSION: There is a selectivity of TRAIL potency to induce apoptosis in gastric cancer cells of different cell lines. The anticancer potency of TRAIL is associated with the decreased expression of NF-kappaB and survivin and increased expression of Caspase3 of gastric cancer cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695762      PMCID: PMC4717071          DOI: 10.3748/wjg.v10.i1.22

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  52 in total

1.  TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.

Authors:  Christine Odoux; Andreas Albers; Andrew A Amoscato; Michael T Lotze; Michael K K Wong
Journal:  Int J Cancer       Date:  2002-02-01       Impact factor: 7.396

2.  Expression of bcl-2 protein in gastric carcinoma and its significance.

Authors:  Hai-Feng Liu; Wei-Wen Liu; Dian-Chun Fang; Rong-Pu Men
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

3.  Killing effect of TNF-related apoptosis inducing ligand regulated by tetracycline on gastric cancer cell line NCI-N87.

Authors:  X C Wei; X J Wang; K Chen; L Zhang; Y Liang; X L Lin
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.

Authors:  A Suzuki; M Hayashida; T Ito; H Kawano; T Nakano; M Miura; K Akahane; K Shiraki
Journal:  Oncogene       Date:  2000-07-06       Impact factor: 9.867

5.  Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.

Authors:  Franco Silvestris; Paola Cafforio; Marco Tucci; Franco Dammacco
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

Review 6.  TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy.

Authors:  H Wajant; K Pfizenmaier; P Scheurich
Journal:  Apoptosis       Date:  2002-10       Impact factor: 4.677

7.  Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways.

Authors:  Edward M Conway; Saskia Pollefeyt; Marta Steiner-Mosonyi; Wei Luo; Astrid Devriese; Florea Lupu; Francoise Bono; Nathalie Leducq; Frederique Dol; Paul Schaeffer; Désiré Collen; Jean-Marc Herbert
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

8.  Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.

Authors:  Charles M Rudin; Zejia Yang; Lisa M Schumaker; David J VanderWeele; Kenneth Newkirk; Merrill J Egorin; Eleanor G Zuhowski; Kevin J Cullen
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

9.  Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.

Authors:  Dong-Myung Kim; Sun-Young Koo; Kiwan Jeon; Min Hyung Kim; Jinho Lee; Chang Yong Hong; ShinWu Jeong
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

Review 10.  NF-kappaB in cancer: a marked target.

Authors:  Anning Lin; Michael Karin
Journal:  Semin Cancer Biol       Date:  2003-04       Impact factor: 15.707

View more
  22 in total

1.  MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma.

Authors:  Yuanyuan Wang; Min Li; Wenqiao Zang; Yunyun Ma; Na Wang; Ping Li; Tao Wang; Guoqiang Zhao
Journal:  Cell Oncol (Dordr)       Date:  2013-09-03       Impact factor: 6.730

2.  CdSe/ZnS quantum dots induce photodynamic effects and cytotoxicity in pancreatic cancer cells.

Authors:  Si-Jia He; Jia Cao; Yong-Sheng Li; Jia-Chun Yang; Min Zhou; Chun-Ying Qu; Yi Zhang; Feng Shen; Ying Chen; Ming-Ming Li; Lei-Ming Xu
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

3.  Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria.

Authors:  Katalin Nagy; Kinga Székely-Szüts; Kamel Izeradjene; Leslie Douglas; Mike Tillman; Helga Barti-Juhász; Massimo Dominici; Carlotta Spano; Gian Luca Cervo; Pierfranco Conte; Janet A Houghton; Rudolf Mihalik; László Kopper; István Peták
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

4.  Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo.

Authors:  Motoo Nagane; Saki Shimizu; Eiji Mori; Shiro Kataoka; Yoshiaki Shiokawa
Journal:  Neuro Oncol       Date:  2010-02-11       Impact factor: 12.300

5.  Effect of operation-synchronizing transfusion of apoptotic spleen cells from donor rats on acute rejection of recipient rats after liver transplantation.

Authors:  Jing Liu; Yi Gao; Shuan Wang; Er-Wei Sun; Yu Wang; Zhi Zhang; Yi-Qiang Shan; Shi-Zheng Zhong
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

6.  The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway.

Authors:  Sung-Chul Lim; Keshab Raj Parajuli; Song Iy Han
Journal:  Tumour Biol       Date:  2015-11-28

7.  The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population.

Authors:  Li Yang; Huaijun Zhu; Bo Zhou; Haijuan Gu; Hongli Yan; Naping Tang; Hanzhang Dong; Qingmin Sun; Rihong Cong; Guoyu Chen; Bin Wang
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

8.  Swainsonine protects H9c2 cells against lipopolysaccharide-induced apoptosis and inflammatory injury via down-regulating miR-429.

Authors:  Hongyan Lv; Su Zhang; Xiaohong Hao
Journal:  Cell Cycle       Date:  2019-12-26       Impact factor: 4.534

Review 9.  Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.

Authors:  Yan Liu; Lin Li; Haiyan Qi; Yan Gao; Sha Liu; Chongan Xu
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Biological Mechanisms Induced by Soybean Agglutinin Using an Intestinal Cell Model of Monogastric Animals.

Authors:  Li Pan; Yan Liu; Hainan Lan; Nan Bao; Yuan Zhao; Hui Sun; Guixin Qin; Mohammed Hamdy Farouk
Journal:  Front Vet Sci       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.